A revelation while scuba diving leads to a novel device designed to reduce IOP pressure. Dr. Emily Schehlein speaks with Drs. Katherine S. Peters and Daniel Terveen about their study on the FSYX Ocular Pressure Adjusting Pump, from their recent Ophthalmology Glaucoma article, “Manometric Intraocular Pressure Reduction with Negative Pressure Using Ocular Pressure Adjusting Pump Goggles”

Manometric Intraocular Pressure Reduction with Negative Pressure Using Ocular Pressure Adjusting Pump Goggles. Peters, Katherine S. et al. Ophthalmology Glaucoma, Volume 8, Issue 1, 22 – 27.

How do GLP-1 receptor agonists and metformin affect glaucoma risk in patients with Type 2 diabetes? Join Dr. Ike Ahmed and Jawad Muayad as they discuss the data on diabetes treatments and glaucoma risk with Dr. Emily Schehlein. From their Ophthalmology article, “Comparative Effects of Glucagon-like Peptide 1 Receptor Agonists and Metformin on Glaucoma Risk in Patients with Type 2 Diabetes.”

Comparative Effects of Glucagon-like Peptide 1 Receptor Agonists and Metformin on Glaucoma Risk in Patients with Type 2 Diabetes. Muayad, Jawad et al. Ophthalmology. In press.

What is the relationship between blood pressure and visual field progression? Can systemic arterial blood pressure be used to assess the risk of glaucomatous progression? Dr. Emily Schehlein finds out from Dr. David S. Greenfield, author of Ophthalmology’s “Relationship between Blood Pressure and Rates of Glaucomatous Visual Field Progression: The Vascular Imaging in Glaucoma Study.”

Relationship between Blood Pressure and Rates of Glaucomatous Visual Field Progression. Donkor, Richard et al. Ophthalmology, Volume 132, Issue 1, 30 - 38